News & Events
Can a diet high in processed fat and sugar and Type 2 diabetes cause degeneration of intervertebral discs in the spine?
Last month, art and design students from across the country gathered in New York City to participate in the first-ever Biodesign Summit, the culmination of a semester-long challenge to conceptualize a biotech product for the future.
A few snippets of protein extracted from the fossil of an extinct species of giant beaver are opening a new door in paleoproteomics, the study of ancient proteins.
Discovery of rules that govern a variation of the CRISPR/Cas9 gene-editing method makes it possible to use living cells to manufacture valuable metabolic compounds like pharmaceuticals and nutraceuticals.
Suicide allows bacteria found in opportunistic infections to create an antibiotic tolerant biofilm, according to a team including researchers at Rensselaer Polytechnic Institute (RPI).
A new method to control the activity of neurons in mice, devised by scientists at Rensselaer Polytechnic Institute (RPI) and Rockefeller University, uses magnetic forces to remotely control the flow of ions into specifically targeted cells.
Five members of the Rensselaer faculty have been selected for induction into the College of Fellows of the American Institute for Medical and Biological Engineering.
Professor Steven Cramer received a 2016 American Chemical Society award. Cramer is recognized “for contributions to a molecular-level understanding, adsorption isotherm formalisms, and the development of chromatographic bioprocesses for the purification of biopharmaceuticals.”
Doctoral candidate Matthew Dion ’12 and his partners in Amp It Up have been awarded a prestigious EXIST Business Start-up Grant to help fund their invention—an inexpensive device that could make prosthetic legs readily available to amputees in developing nations.
Using pressure to perturb folded proteins, biotechnology researcher Catherine Royer will explore the path of a protein from its unfolded to folded state, advancing our ability to optimize proteins for industrial and pharmaceutical applications.
Federal investments in research are paying off in scientific breakthroughs that are “unleashing the power and potential of proteins” in humans.